'Going to have to sell my house ... or die'
Medicare drug plan gap has some paying dearly
By Keith Darcé
STAFF WRITER
July 16, 2006
Frank Harrison says he's facing a choice between his health and his house. When the Spring Valley retiree hit a coverage cap in his federal prescription drug plan in early June, his monthly medicine costs skyrocketed from about $250 to about $1,800, largely because of two expensive immune suppression drugs that he has taken since a kidney transplant six years ago.
The 62-year-old former computer company operations manager, whose main income comes from Social Security disability benefits, stopped taking one of the drugs, which cost about $575 a month, so that he could keep paying his $750 mortgage payment. “What it boils down to pretty soon is that I'm going to have to sell my house. It's either that or die,” he said.
Harrison is among the 3.4 million seniors and disabled Americans who have begun to fall into a gap in Medicare Part D coverage. They must pay the full price for drugs after they've spent $2,250 in co-payments and until their out-of-pocket costs reach $5,100 for the year. Those in the so-called “doughnut hole” are likely to cut back on medicines to save money even if doing so jeopardizes their health, according to some research.
(snip)
Congress created the Part D gap when lawmakers created the drug insurance program in 2003. The measure was added to reduce the program's overall cost. Lawmakers reasoned that only a tiny portion of Part D participants would reach the gap and most would be without coverage only for a short period.
(snip)
That's what Kaiser Permanente researcher John Hsu found when he studied about 200,000 Medicare beneficiaries in 2003 who participated in a more limited government prescription drug program that predated Part D. The results, published in the June 1 edition of The New England Journal of Medicine, found that people whose drug benefits were capped at $1,000 a year had higher rates of emergency room visits, hospitalization and death than those with unlimited coverage. Hsu attributed the increases to people ending drug treatments once the insurance cap was reached. The cost for additional medical care offset the lower drug cost savings created by the cap, he reported.
(snip)
Find this article at:
http://www.signonsandiego.com/uniontrib/20060716/news_1b16drug.html